Modern Retina | Ophthalmology News, Events & Expert Insights
October 18th 2024. Thomas Aaberg, Jr, MD, Neurotech's Chief Medical Officer, shared some insights on the company's recent presentation as well as their upcoming presentations at the annual American Academy of Ophthalmology meeting being held in Chicago, Illinois. Steven Yeh, MD, shares overview of recent and upcoming presentations.
Dealing with complications of silicone oil - Modern Retina
Sep 2, 2022 · Re-detachment after silicone oil removal is a major complication, with rates varying up to 30%. Suspected ERP and ERMs can be diagnosed by direct examination and OCT and removed when silicone oil is removed from the eye. Peripheral 360-degree laser retinopexy and scleral encircling band significantly diminish the rate of re-detachment.
AAO 2023: San Francisco: Where All of Ophthalmology Meets®
Oct 20, 2023 · The American Academy of Ophthalmology (AAO) 2023 annual meeting is returning home to San Francisco on Friday November 3 through Monday November 6. The venue is the George R. Moscone Center. In addition to the main program, the Subspecialty Days are set for Friday and Saturday, November 3 and 4. AAO is continuing with the opportunity for ...
Distinction between lamellar holes and macular pseudoholes
Mar 12, 2018 · Dr. Thompson defined pseudomacular holes as a clinical diagnosis as seen via slit lamp biomicroscopy versus optical coherence tomography (OCT). “Use pseudomacular holes only to describe the biomicroscopic appearance,” he added. In contrast, a lamellar macular hole is defined by the appearance of the fovea via OCT.
True-to-life retinal imaging with the new ultrawidefield color RGB …
Jun 23, 2024 · The introduction of red/green/blue (RGB) color is a welcome addition to ultrawidefield imaging that will aid in the screening and detection of retinal diseases. Ultrawidefield (UWF) imaging is defined as retinal imaging beyond the vortex vein ampullae in all quadrants with a single capture, equating to a 110° to 220° view of the retina. 1 ...
Ocular Therapeutix Inc. screens and doses the first 3 subjects in …
Feb 13, 2024 · These 3 participants have received their first aflibercept injection for the treatment of wet AMD. Ocular Therapeutix Inc. screened the first 3 subjects in the Phase 3 SOL-1 clinical trial of AXPAXLI™ (axitinib intravitreal implant, also known as OTX-TKI) for the treatment of wet age-related macular degeneration (wet AMD).
Study: 100x improvement in sight detected after gene therapy trial
Sep 13, 2024 · The vision of patients diagnosed with a rare inherited condition that causes them to lose much of their sight early in their childhood was demonstrated to be 100 times better after they received gene therapy to address the genetic mutation causing it.. According to the clinical trial, published in The Lancet, some patients even experienced a …
Satellite clinics and other strategies to enhance rural ophthalmology
Jun 18, 2024 · Satellite clinics and other strategies to enhance rural ophthalmology. June 18, 2024. By Brendan Girschek, MD, FRCSC, FACS. News. Article. Modern Retina Digital EditionModern Retina Summer 2024. Volume 4. Issue 2. Proactive communication and leveraging advanced, yet reliable, technologies to maximize efficiency are essential pillars of success.
Opthea makes changes to leadership and hires senior roles
Sep 18, 2024 · Opthea Limited has made changes to the company’s executive leadership in its finance and commercial areas and has made notable hires in its biometrics, clinical operations, and market access departments. In the press release 1 announcing these personnel changes and additions, Opthea’s CEO, Frederic Guerard, PharmD, noted that the decision ...
BETTIS-1 Phase 2 trial enrolls and doses first patient with DME
Aug 15, 2024 · EC-104 is a novel intravitreal (IVT) corticosteroid implant with intended 6 months durable drug release for the treatment of DME. Eclipse Life Sciences has enrolled and dosed its first patient in the BETTIS-1 Phase 2 clinical trial (NCT06536491) for EC-104 fluocinolone acetonide (FA) extended release. This candidate is a novel intravitreal (IVT ...